Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

21-26 results from 26 for query «psoriasis»

18 September, 2014 11:31 AM Sensex Soars Nearly 2%, Gains Most in Over 3 Months

The BSE Sensex and Nifty Indian shares surged nearly 2 per cent on Thursday, posting their biggest daily gain in over three months, on hopes foreign buying would continue as country can better weather any Fed-related volatility due to improving fundamentals. Traders said a report from a news channel that Standard & Poor's would raise its rating on India 7

18 September, 2014 5:19 AM Sun Pharma jumps 2% post Merck deal, analysts bullish

Shares of Sun Pharma jumped over 2 percent intraday on Thursday after it entered into a licensing agreement with Merck for investigational therapeutic antibody Tildrakizumab to be used for treatment of chronic plaque psoriasis. Under terms of the agreement, Sun Pharma will acquire worldwide rights to Tildrakizumab for use in all human indications from Merck 5

17 September, 2014 2:42 PM Merck Licenses Experimental Psoriasis Drug to Sun Pharma

Merck & Co Inc said it has licensed its experimental psoriasis drug to Indian generic maker Sun Pharmaceutical Industries Ltd for $80 million (Rs 480 crore at 1 dollar = 60 rupees). Under the agreement, Sun Pharma will acquire the worldwide rights to the drug, tildrakizumab, for all possible indications. The drug is currently in late-stage trials for use in chronic 2

17 September, 2014 1:48 PM Sun Pharma, Merck & Co Inc ink pact for Tildrakizumab

Pharma major Sun Pharmaceutical Industries today entered into a licensing agreement with Merck & Co Inc for investigational therapeutic antibody candidate, tildrakizumab to be used for treatment of plaque psoriasis. Under terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange 8

16 September, 2014 2:38 AM Epirus, Ranbaxy win India approval for arthritis drug copy

Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year. The company's Indian partner, Ranbaxy Laboratories Ltd , will sell a copycat version of Johnson & Johnson's and Merck & Co Inc's infliximab, an anti-inflammatory drug with annual 22

29 June, 2014 12:42 PM Nine New Drugs Under Clinical Stage: Dr Reddy's

Dr Reddy's Laboratories has said it has nine new drugs in different areas, including metabolic disorders and cardiovascular disorders, Psoriasis and migraine, under clinical development stage. According to a filing with US SEC, the drug maker said as of March 31, 2014, DRL had 20 active products in the proprietary products pipeline, of which nine were in clinical 40